Wandercraft raises €64.3M Series D round
11 June 2025· Paris, France· health, robotics, ai, exoskeletons, software_hardware, b2b, b2c
The funding will support the company's expansion into consumer and industrial applications, including bringing Eve (the self-balancing personal exoskeleton) to market by 2026, scaling clinical use of Atalante X, and developing and deploying the Calvin-40 humanoid robot.
Investors
LeadRenault Group
Also participating
BpifrancePSIM fundTeampact VenturesQuadrant ManagementLBO FranceMutuelles ImpactXAngeCemag InvestMartagon CapitalAG2R LA MONDIALE
About Wandercraft
Stage
Series D
Headquarters
Paris, France
Founded
2012
Team Size
51–200
Sectors
healthroboticsaiexoskeletonssoftware_hardwareb2bb2c